产品
编 号:F756787
分子式:C35H32ClF3N3O10P
分子量:778.06
产品类型
规格
价格
是否有货
结构图
联系客服
产品详情
生物活性:
CREB-IN-1 TFA is a potent, orally active CREB inhibitor (IC50=0.18 μM). CREB-IN-1 TFA inhibits breast cancer cell growth.

体内研究:
CREB-IN-1 TFA (5, 10, 20 mg/kg) shows much improve oral bioavailability at 38%.Pharmacokinetic Parameters of CXCR4 antagonist 4 in mice .routedose(mg/kg) t1/2(h) Tmax(h)Cmax(ng/mL)AUC0-t(ng·hr/mL)AUC0-∞((ng·hr/mL)bioavailability (F%)
IP104.21.0156892910144
PO205.52.007346847938

Mice, 5 mg/kg IV; 10 mg/kg IP; 20 mg/kg PO.Animal Model:Female C57BL/6 mice
Dosage:5, 10, 20 mg/kg (dissolved in 0.1 N NaOH in ddI H2O at 40 mg/mL and further dilutions were made using ddI H2O)
Administration:Showed much improve oral bioavailability at 38%.
Result:Showed much improve oral bioavailability at 38%.

体外研究:
CREB-IN-1 TFA (compound 3) (HEK 293T cells; 100 μM; 24 hours) inhibits CREB-mediated gene transcription with an IC50 of 0.18 μM.CREB-IN-1 TFA (100 μM; 3 days) shows potent activities in MDA-MB-231 (GI50=0.38 μM) and MDA-MB-468 (GI50=0.021 μM) cells.
产品资料